Medy-Tox Statistics

Total Valuation

Medy-Tox has a market cap or net worth of KRW 829.97 billion. The enterprise value is 895.75 billion.

Market Cap	829.97B
Enterprise Value	895.75B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Sep 27, 2024

Share Statistics

Medy-Tox has 6.73 million shares outstanding. The number of shares has decreased by -49.34% in one year.

Current Share Class	n/a
Shares Outstanding	6.73M
Shares Change (YoY)	-49.34%
Shares Change (QoQ)	-17.85%
Owned by Insiders (%)	19.80%
Owned by Institutions (%)	9.73%
Float	4.96M

Valuation Ratios

The trailing PE ratio is 183.79 and the forward PE ratio is 19.20.

PE Ratio	183.79
Forward PE	19.20
PS Ratio	3.43
PB Ratio	1.76
P/TBV Ratio	n/a
P/FCF Ratio	286.10
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.01, with an EV/FCF ratio of 308.77.

EV / Earnings	194.94
EV / Sales	3.64
EV / EBITDA	23.01
EV / EBIT	43.37
EV / FCF	308.77

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.19.

Current Ratio	1.28
Quick Ratio	0.74
Debt / Equity	0.19
Debt / EBITDA	2.41
Debt / FCF	31.32
Interest Coverage	8.32

Financial Efficiency

Return on equity (ROE) is 1.14% and return on invested capital (ROIC) is 2.12%.

Return on Equity (ROE)	1.14%
Return on Assets (ROA)	1.99%
Return on Capital (ROIC)	2.12%
Revenue Per Employee	350.29M
Profits Per Employee	6.54M
Employee Count	703
Asset Turnover	0.40
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.03%
50-Day Moving Average	173,330.00
200-Day Moving Average	161,702.00
Relative Strength Index (RSI)	21.46
Average Volume (20 Days)	66,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medy-Tox had revenue of KRW 246.25 billion and earned 4.59 billion in profits. Earnings per share was 670.87.

Revenue	246.25B
Gross Profit	151.04B
Operating Income	19.41B
Pretax Income	12.86B
Net Income	4.59B
EBITDA	37.69B
EBIT	19.41B
Earnings Per Share (EPS)	670.87

Full Income Statement

Balance Sheet

The company has 30.23 billion in cash and 90.85 billion in debt, giving a net cash position of -60.63 billion or -9,006.52 per share.

Cash & Cash Equivalents	30.23B
Total Debt	90.85B
Net Cash	-60.63B
Net Cash Per Share	-9,006.52
Equity (Book Value)	477.74B
Book Value Per Share	70,206.93
Working Capital	35.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.56 billion and capital expenditures -7.66 billion, giving a free cash flow of 2.90 billion.

Operating Cash Flow	10.56B
Capital Expenditures	-7.66B
Free Cash Flow	2.90B
FCF Per Share	430.98

Full Cash Flow Statement

Margins

Gross margin is 61.33%, with operating and profit margins of 7.88% and 2.26%.

Gross Margin	61.33%
Operating Margin	7.88%
Pretax Margin	5.22%
Profit Margin	2.26%
EBITDA Margin	15.30%
EBIT Margin	7.88%
FCF Margin	1.18%

Dividends & Yields

This stock pays an annual dividend of 1,100.00, which amounts to a dividend yield of 0.87%.

Dividend Per Share	1,100.00
Dividend Yield	0.87%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	151.21%
Buyback Yield	49.34%
Shareholder Yield	50.22%
Earnings Yield	0.54%
FCF Yield	0.35%

Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 28, 2022
Split Type	Forward
Split Ratio	1.05

Scores

Medy-Tox has an Altman Z-Score of 7.28.

Altman Z-Score	7.28
Piotroski F-Score	n/a